SELP and liver dysplastic nodule: The high similarity with Ebihara’s study confirms the reliability and accuracy of the results, which suggest that P-selectin is a very promising biomarker for DN and that dilazep is a prospective drug to improve renal function in DN with the decline of p-selectin.